Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.519 USD | +0.23% | +2.00% | -4.23% |
03-22 | Sangamo Therapeutics Prices $24 Million Registered Direct Offering | MT |
03-14 | Sangamo Therapeutics Pushes Neurology Programs Toward Clinical Development, Wedbush Says | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- SGMO Stock
- Revisions Sangamo Therapeutics, Inc.